SYNLOGIC, INC. Other Nonoperating Expense
SYNLOGIC, INC. (SYBX) reported Other Nonoperating Expense of $5.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2019-03-12
- SYNLOGIC, INC. other nonoperating expense for the quarter ending 2018-12-31 was $0.00.
- SYNLOGIC, INC. other nonoperating expense for the quarter ending 2018-09-30 was $1.00K, a 91.67% decline year-over-year.
- SYNLOGIC, INC. other nonoperating expense for the quarter ending 2018-06-30 was $3.00K, a 40.00% decline year-over-year.
- SYNLOGIC, INC. other nonoperating expense for the quarter ending 2018-03-31 was $1.00K, a 50.00% decline year-over-year.
- SYNLOGIC, INC. other nonoperating expense for fiscal 2018 was $5.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.00K derived: sum of 2 quarters · filed 2019-03-12 | $4.00K derived: sum of 3 quarters · filed 2019-03-12 | $5.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $1.00K 10-Q · filed 2018-11-13 | $4.00K derived: sum of 2 quarters · filed 2018-11-13 | $5.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.00K 10-Q · filed 2018-08-09 | $4.00K 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $1.00K 10-Q · filed 2018-05-15 | |||
| 2017-09-30 | $12.00K 10-Q · filed 2018-11-13 | $17.00K derived: sum of 2 quarters · filed 2018-11-13 | $19.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $5.00K 10-Q · filed 2018-08-09 | $7.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $2.00K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |